Antibody-drug conjugates and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11384150
APP PUB NO 20200190199A1
SERIAL NO

16467655

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An immunoconjugate, comprising an anti-EGFR antibody or a binding fragment thereof, and a kinase inhibitor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEVELOPMENT CENTER FOR BIOTECHNOLOGYNO 101 LANE 169 KANGNING ST XIZHI DIST NEW TAIPEI CITY 22180 TAIWAN
TUNGHAI UNIVERSITYNO 1727 SEC 4 TAIWAN BLVD XITUN DIST TAICHUNG CITY 407224

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chao, Wei-Ting Taichung, TW 3 5
Chuang, Shih-Hsien New Taipei, TW 23 38
Hsu, Hui-Jan New Taipei, TW 2 3
Lin, Wun-Huei New Taipei, TW 3 4
Sun, Wei-Ting New Taipei, TW 8 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 12, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 12, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 12, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00